BRCA1 is a tumour suppressor protein involved in many important pathways such as DNA repair, cell cycle regulation, apoptosis, spindle formation and telomere regulation. BRCA1 germline mutations confer the highest risk to breast cancer. Furthermore, reduced levels of BRCA1 are also observed in many sporadic breast cancers. Despite the obvious importance of BRCA1, genetic screening is usually restricted to BRCA1 exons and intronexon boundaries. The possibility that mutations exist outside these regions has not been fully investigated and may be responsible for breast cancer predisposition in a subset of . However, identifying regulatory elements outside BRCA1 and determining whether mutations in these elements contribute to BRCA1 deregulation is still relatively unexplored. This project aims to expand the repertoire of BRCA1 long-range regulatory elements using gene conformation techniques such as chromosome conformation capture (3C) and its derivatives. The project hypothesis is that defects in long-range regulatory elements of BRCA1 transcription contribute to breast cancer predisposition.Using a candidate 3C approach, we identified a potential cis-regulatory element, called PRE1, located approximately 157 kb downstream of the BRCA1 promoter. The frequency of this interaction increased with estrogen stimulation, suggesting that chromatin looping is associated with BRCA1 transcription. Bioinformatic analysis showed that this element is flanked by DNase hypersensitivity and histone marks, which suggests it is an enhancer of BRCA1. This was confirmed by luciferase reporter assays which demonstrated that PRE1 acts as a weak enhancer, resulting in a 10% increase in BRCA1 promoter activity. Using ChIP we showed that the TF c-Myc binds to both PRE1 and the BRCA1 promoter, however depletion of c-Myc RNA levels did not alter PRE1s enhancer activity. Using a genome-wide circular-3C (4C) approach, we identified a potential trans-regulatory silencer element located 5kb upstream of G2E3 on chromosome 14. This trans-interaction was 2 validated by 3C in MCF7 cells, which suggests that the interaction is potentially functional.Consistent with this, bioinformatic analysis showed that this element, called PRE2, is flanked by DNase hypersensitivity and strong histone marks indicative of a silencer.Notably, luciferase assays showed that a modified version of PRE2 could repress BRCA1 promoter activity, resulting in a 3-fold decrease in activity. This research project has provided the first important steps to fully understanding the molecular pathways underlying BRCA1 regulation. The identification and characterisation of novel long-range control elements of breast cancer genes will immediately improve genetic screening procedures, and permit the development of more specific therapeutic approaches.3